Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Pneumonia Therapeutics
... CAGR of 6.7% over the analysis period 2024-2030. Pneumonia Drugs, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$6.8 Billion by the end of the analysis ... Read More
-
Spinal Trauma Devices
... at a CAGR of 5.6% over the analysis period 2024-2030. Internal Fixation Devices, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$4.9 Billion by the end ... Read More
-
TNF Inhibitors
... CAGR of 6.4% over the analysis period 2024-2030. Rheumatoid Arthritis Application, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$22.7 Billion by the end of the ... Read More
-
Intravaginal Insemination
... CAGR of 7.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$130.1 Million While China is Forecast to Grow at 10.8% CAGR The Intravaginal Insemination market in the U.S. is estimated at ... Read More
-
Tobacco Alternative Gums
... at a CAGR of 6.0% over the analysis period 2024-2030. 2 mg Nicotine Content Gums, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$3.5 Billion by ... Read More
-
Ulcerative Colitis Therapeutics
... at a CAGR of 4.3% over the analysis period 2024-2030. Oral Administration, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$5.6 Billion by the end of ... Read More
-
Family Planning Centers
... at a CAGR of 3.3% over the analysis period 2024-2030. Birth Control Clinics, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$4.5 Billion by the end ... Read More
-
Brain Tumor Diagnosis and Treatment
... Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Primary Brain Tumor, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.3 ... Read More
-
Carotid Stents
... CAGR of 8.6% over the analysis period 2024-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$4.3 Billion by the end of the ... Read More
-
Cosmetic Procedures and Products
... 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Facial Injectables, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$22.1 Billion by the ... Read More
-
Cardiovascular Drugs
... CAGR of 3.4% over the analysis period 2024-2030. Anticoagulants, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$57.7 Billion by the end of the analysis period. ... Read More
-
Antibiotics
... 3.1% over the analysis period 2024-2030. Penicillin, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$15.7 Billion by the end of the analysis period. Growth in ... Read More
-
Multiple Myeloma Therapeutics
... at a CAGR of 14.5% over the analysis period 2024-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$37.6 Billion by the ... Read More
-
Cognitive Assessment and Training
... 2030, growing at a CAGR of 26.9% over the analysis period 2024-2030. Cognitive Assessment and Training Solutions, one of the segments analyzed in the report, is expected to record a 24.9% CAGR and reach US$17.4 ... Read More
-
Prostate Cancer Therapeutics
... at a CAGR of 6.6% over the analysis period 2024-2030. Hormone Therapy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$21.0 Billion by the end of ... Read More
-
Cervical Cancer Endoscopic Devices
... 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Optical Colposcopes, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$668.1 Million by the ... Read More
-
Lacrimal Duct Stent Tubes
... 2030, growing at a CAGR of 2.1% over the analysis period 2024-2030. Bicanalicular Tubes, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$35.0 Million by the ... Read More
-
Antacids
... 2.2% over the analysis period 2024-2030. Proton Pump Inhibitors, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$2.2 Billion by the end of the analysis period. ... Read More
-
Energy-based Therapeutics
... CAGR of 3.6% over the analysis period 2024-2030. Laser-based Technology, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.6 Billion by the end of the analysis ... Read More
-
Allergy Diagnostics
... CAGR of 10.0% over the analysis period 2024-2030. Allergy Diagnostics Assay Kits, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$4.5 Billion by the end of ... Read More
-
Sex Toys
... CAGR of 7.9% over the analysis period 2024-2030. Adult Vibrators, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$36.8 Billion by the end of the analysis ... Read More
-
Postpartum Hemorrhage (PPH) Treatment Devices
... Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Uterine Balloon Tamponade, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$521.7 ... Read More
-
Clear Aligners
... CAGR of 23.8% over the analysis period 2024-2030. Adult Clear Aligners, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$14.9 Billion by the end of the ... Read More
-
Doxorubicin
... 5.8% over the analysis period 2024-2030. Breast Cancer Application, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$374.1 Million by the end of the analysis period. ... Read More
-
Contract Research Organization Services (CROs)
... Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Clinical Research Services, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$76.7 ... Read More
Research Assistance
